Skip to main content
. 2013 Sep 30;8(9):e75926. doi: 10.1371/journal.pone.0075926

Table 3. Postdiagnosis menopausal symptoms in association with breast cancer recurrence by body-mass-index (BMI), SBCSS (n=4,842).

BMI (universal cutoff point)
Experience with menopausal symptoms Overweight/obese (≥25 kg/m2) n=1,705
Not overweight/obese (<25 kg/m2) n=3,137
cases HRa (95% CI) cases HRa (95% CI) P interaction
Any menopausal symptomb
No 815 1.00 (reference) 1318 0.98 (0.78-1.22)
Yes 890 1.05 (0.83-1.33) 1819 0.84 (0.67-1.04) 0.18
Hot flashes
No 1035 1.00 (reference) 1669 0.95 (0.78-1.15)
Yes 670 1.01 (0.79-1.29) 1468 0.78 (0.64-0.99) 0.24
Night sweats
No 1127 1.00 (reference) 1999 0.88 (0.73-1.07)
Yes 578 0.95 (0.74-1.22) 1138 0.82 (0.66-1.03) 0.90
Vaginal dryness
No 1574 1.00 (reference) 2841 0.88 (0.75-1.03)
Yes 131 0.97 (0.61-1.54) 296 0.86 (0.61-1.22) 0.97
No. of menopausal symptoms
0 815 1.00 (reference) 1318 0.98 (0.78-1.22)
1 455 1.20 (0.92-1.58) 870 0.85 (0.66-1.11)
≥2 435 0.88 (0.65-1.20) 949 0.81 (0.62-1.05) 0.51
a

HRs are adjusted for age at diagnosis (continuous), education (categories), number of pregnancies (categories), marital status, history of chronic disease (Charlson comorbidity score 0/≥1), perceived quality of life (categories), treatment received (radiotherapy, chemotherapy, immunotherapy, and/or tamoxifen; yes/no), TNM, and ER and PR status

b

Included hot flashes, night sweats, and/or vaginal dryness